RecruitingNot ApplicableNCT07433998

Effect of a Ginger-Based Beverage on Inflammation, Oxidative Stress, and Endothelial Function

Study of the Effect of a Ginger-based Functional Beverage on Markers of Inflammation, Oxidative Stress, and Endothelial Damage.

Sponsor

Javier Marhuenda

Enrollment

50 participants

Start Date

Mar 1, 2026

Study Type

INTERVENTIONAL

Conditions

Cardiometabolic Risk Factors Oxidative Stress Inflammation Biomarkers

Summary

Randomized, double-blind, parallel, placebo-controlled clinical trial designed and conducted to evaluate the effect of daily consumption of ginger, on parameters related to inflammation, oxidative stress, and endothelial damage in adults with excess adiposity.

Eligibility

Min Age: 23 YearsMax Age: 65 Years

Inclusion Criteria14

Male and female participants.
Age between 23 and 65 years.
Body mass index (BMI) > 27.5 kg/m².
Absence of diagnosed chronic diseases.
Not receiving pharmacological treatment or dietary supplementation on a regular basis.
Ability to understand the study procedures and willingness to comply with study requirements.
Ongoing chronic pharmacological treatment or active use of dietary supplements.
Major surgery within the previous three months.
Current smokers or recent former smokers (less than six months since cessation).
History of clinically relevant food allergies or eating disorders.
Concurrent participation in another clinical trial or research study.
Pregnancy or breastfeeding.
Following an active weight-loss diet.
Investigator's judgment of unsuitability for study participation.